A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy
Clinical trial NCT06269393 · COMPLETED
Trial details
- NCT number
- NCT06269393
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-04-03
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.